Difficulty: Medium
Average Score: 92%
Practice
The client is taking a glycoprotein IIB/IIIA receptor antagonist for the prevention of stroke. What drug is the client likely taking?
Correct answer
D
Rationale
Abciximab, a GP IIb/IIIa inhibitor, blocks platelet aggregation, used acutely to prevent thrombosis (e.g., post-PCI), not typically for stroke.